Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Mercia Asset Management CFO raises stake

(Sharecast News) - Mercia Asset Management revealed on Thursday that chief financial officer Martin Glanfield had acquired 145,829 ordinary shares in the AIM-listed asset manager. Glanfield, who took over CFO in October 2014, purchased the shares on Wednesday at an average price of 28.80p each, for a total value of £41,998.75.

Following the transaction, Glanfield holds a beneficial interest in 1.74m ordinary Mercia shares, representing approximately 0.4% of the company's issued share capital.

As of 1615 GMT, Mercia shares were down 0.78% at 28.78p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Mercia Asset Management (MERC) Director name: Glanfield,Martin James Amount purchased: 145,829 @ 28.80p Value: �41,998.75

Trident Royalties (TRR) Director name: Hughes,Richard John Amount purchased: 115,000 @ 31.88p Value: �36,662.00

Totally (TLY) Director name: Stilwell ,Simon Amount purchased: 550,000 @ 6.10p Value: �33,550.00

Trident Royalties (TRR) Director name: Hughes,Richard John Amount purchased: 59,000 @ 32.80p Value: �19,352.00

Totally (TLY) Director name: Stilwell ,Simon Amount purchased: 250,000 @ 6.17p Value: �15,425.00

Elementis (ELM) Director name: Woon,Clement Amount purchased: 10,000 @ 121.00p Value: �12,100.00

Totally (TLY) Director name: Stilwell ,Simon Amount purchased: 200,000 @ 6.00p Value: �12,000.00

Trident Royalties (TRR) Director name: Hughes,Richard John Amount purchased: 26,000 @ 31.70p Value: �8,242.00

Top Director Sells

London Stock Exchange Group (LSEG) Director name: Brand,Martin Amount sold: 37,329 @ 10,123.00p Value: �3,778,814.80

London Stock Exchange Group (LSEG) Director name: Brand,Martin Amount sold: 27,945 @ 10,123.00p Value: �2,828,872.44

Altitude Group (ALT) Director name: Varley,Martin Roy Amount sold: 578,334 @ 35.51p Value: �205,354.84

Altitude Group (ALT) Director name: Varley,Martin Roy Amount sold: 50,000 @ 40.13p Value: �20,062.50

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 1,085 @ 461.50p Value: �5,007.27

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 735 @ 460.50p Value: �3,384.68

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 597 @ 455.00p Value: �2,716.35

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 452 @ 462.00p Value: �2,088.24

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 388 @ 456.00p Value: �1,769.28

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 372 @ 463.00p Value: �1,722.36

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 226 @ 462.50p Value: �1,045.25

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 226 @ 456.50p Value: �1,031.69

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 200 @ 453.00p Value: �906.00

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 134 @ 459.00p Value: �615.06

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 130 @ 454.00p Value: �590.20

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 127 @ 457.00p Value: �580.39

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 100 @ 459.50p Value: �459.50

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 100 @ 457.50p Value: �457.50

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 74 @ 460.00p Value: �340.40

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 28 @ 452.00p Value: �126.56

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 26 @ 455.50p Value: �118.43

Share this article

Related Sharecast Articles

Director dealings: Tracsis director snaps up shares
(Sharecast News) - Tracsis revealed on Wednesday that non-executive director Tracy Sheedy had acquired 950 ordinary shares in the AIM-listed transport software provider.
Director dealings: Admiral director raises stake
(Sharecast News) - Admiral Group revealed on Tuesday that non-executive director Justine Roberts had acquired 1,044 ordinary shares in the FTSE 100-listed insurer.
Director dealings: Creo Medical chairman raises stake
(Sharecast News) - Creo Medical revealed on Monday that chairman Kevin Crofton had acquired 1.17m ordinary shares in the London-listed medical device company.
Director dealings: Rentokil Initial director makes share purchase
(Sharecast News) - Rentokil Initial revealed on Friday that non-executive director Brian Baldwin had acquired 7.5m ordinary shares in the FTSE 100-listed pest control business.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.